Manipulation of the nerve growth factor network in prostate cancer
- 16 February 2007
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 16 (3) , 303-309
Abstract
(2007). Manipulation of the nerve growth factor network in prostate cancer. Expert Opinion on Investigational Drugs: Vol. 16, No. 3, pp. 303-309. doi: 10.1517/13543784.16.3.303Keywords
This publication has 36 references indexed in Scilit:
- The p75NTR tumor suppressor induces cell cycle arrest facilitating caspase mediated apoptosis in prostate tumor cellsBiochemical and Biophysical Research Communications, 2006
- A novel function of differentiation revealed by cDNA microarray profiling of p75NTR-regulated gene expressionDifferentiation, 2005
- Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinomaThe Prostate, 2005
- Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitizationPain, 2005
- Novel insights into the implication of the IGF-1 network in prostate cancerTrends in Molecular Medicine, 2005
- Agents in development for prostate cancer preventionExpert Opinion on Investigational Drugs, 2004
- Hormonal treatment for prostate cancerExpert Opinion on Investigational Drugs, 2001
- Physiology of the NeurotrophinsAnnual Review of Neuroscience, 1996
- Expression of Nerve Growth Factor and Nerve Growth Factor Receptor Genes in Human Tissues and in Prostatic Adenocarcinoma Cell LinesJournal of Neurochemistry, 1992
- Human prostate cancer model: Roles of growth factors and extracellular matricesJournal of Cellular Biochemistry, 1992